Just in time for the holiday season, Lilly unveiled its multi-pronged campaign to tie in Alzheimer’s awareness with cultural ...
Novo Nordisk said this morning that a pair of large, placebo-controlled clinical trials testing an oral version of its GLP-1 ...
Eli Lilly has secured marketing authorization from India's CDSCO for its Alzheimer's drug, donanemab. This new ...
Eli Lilly receives CDSCO approval for donanemab, a new Alzheimer's treatment targeting early symptomatic stages of the ...
GLP-1 drugs like Wegovy and Zepbound have been racking up sales and new indications, as researchers learn more about how the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback